Full-Time
Posted on 6/18/2024
Provides compact MRI solutions for urology
$80k - $130kAnnually
Junior, Mid
Oakland, CA, USA
You match the following Promaxo's candidate preferences
Employers are more likely to interview you if you match these preferences:
Promaxo provides MRI solutions specifically designed for prostate imaging and image-guided biopsies. Their MRI systems are compact and modular, allowing private medical practices, especially those in urology, to perform scans on-site without the need for extensive facility upgrades. This setup reduces the time patients wait for scans and follow-up visits, enhancing the quality of care and reducing anxiety. Promaxo's technology uses low magnetic fields to generate high-quality images quickly and comfortably for patients. The company differentiates itself from competitors by offering a cost-effective solution with low capital and operating costs, enabling clinics to recover their investment in less than a year. Promaxo's goal is to make MRI technology more accessible and affordable, ultimately improving patient care.
Company Size
51-200
Company Stage
Seed
Total Funding
$48.1M
Headquarters
Oakland, California
Founded
2016
Help us improve and share your feedback! Did you find this helpful?
Health
Family
Community Activties
Convenience
Time Away
Growth
PENNINGTON, N.J., June 18, 2024 /PRNewswire/ -- Zynext Ventures USA LLC (Zynext Ventures), the Venture Capital (VC) arm of Zydus Lifesciences, dedicated to fostering disruptive healthcare innovations, announced its investment in Promaxo Inc. (Promaxo), a leading US-based developer of portable low-field MRI systems and minimally invasive robotics.Promaxo's innovative technology aims to revolutionize patient care by enabling point-of-care imaging and intervention. Their portable low-field MRI systems enable early diagnosis and treatment in a wider range of healthcare settings. The portable Promaxo MRI system is the first in the USA to receive an FDA 510(k) clearance for prostate biopsy and treatment. Unlike traditional MRI, the Promaxo MRI is open and compact with a limited fringe field and can be placed in a clinic or operating room. The system is also designed to be compatible with robotic procedures
The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.
Further, in June 2022, Promaxo Inc. launched an in-office MRI system-a single-sided MRI integrated with an AI-based imaging system-at East Valley Urology Centre.
Promaxo was founded by a team of entrepreneurs and healthcare innovators to develop a minimally-invasive and patient-centric MRI and robotic platform.
OAKLAND, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Promaxo, Inc. ("Promaxo" or the "Company"), a medical imaging, robotics, and AI technology company, announced today that it has received a direct investment from Fred Moll, M.D., industry pioneer and leader in surgical robotics and minimally invasive surgery, with more than 40 years of experience of building and leading innovative medical device companies. Promaxo also appointed Dr. Moll as strategic advisor."Renowned for his extraordinary track record of success in innovating, developing, and commercializing novel technologies in the field of medical robotics, we are proud to announce that Promaxo has received a direct investment from Dr. Moll, who also joins us as a strategic advisor," said Dr